Efficacy of ginkgo biloba extract as augmentation of venlafaxine in treating post-stroke depression

References

• Robinson RG, Spalletta G. Poststroke depression: a review. Can J Psychiatry. 2010;55:341–349. doi:10.1177/07067437100550060220540828
   PubMed Web of Science ®Google Scholar
• Whyte EM, Mulsant BH, Vanderbilt J, et al. Depression after stroke: a prospective epidemiological study. J Am Geriatr Soc. 2004;52:774–778. doi:10.1111/j.1532-5415.2004.52217.x15086660
   PubMed Web of Science ®Google Scholar
• Meader N, Moe-Byrne T, Llewellyn A, Mitchell AJ. Screening for poststroke major depression: a meta-analysis of diagnostic validity studies. J Neurol Neurosurg Psychiatry. 2014;85(2):198–206. doi:10.1136/jnnp-2012-30419423385849
   PubMed Web of Science ®Google Scholar
• Tu WJ, Dong X, Zhao SJ, et al. Prognostic value of plasma neuroendocrine biomarkers in patients with acute ischaemic stroke. J Neuroendocrinol. 2013;25:771–778. doi:10.1111/jne.1205223701638
   PubMed Web of Science ®Google Scholar
• Zhan Y, Yang YT, You HM, et al. Plasma-based proteomics reveals lipid metabolic and immunoregulatory dysregulation in post-stroke depression. Eur Psychiatry. 2014;29(5):307–315. doi:10.1016/j.eurpsy.2014.03.00424853294
   PubMed Web of Science ®Google Scholar
• Srivastava A, Taly AB, Gupta A, Murali T. Post-stroke depression: prevalence and relationship with disability in chronic stroke survivors. Ann Indian Acad Neurol. 2010;13:123–127. doi:10.4103/0972-2327.6464320814496
   PubMed Web of Science ®Google Scholar
• House A, Dennis M, Hawton K, Warlow C. Methods of identifying mood disorders in stroke patients: experience in the Oxfordshire Community Stroke Project. Age Ageing. 1989;18(6):371–379. doi:10.1093/ageing/18.6.3712629484
   PubMed Web of Science ®Google Scholar
• Liu Z, Cai Y, He J. High serum levels of 8-OHdG are an independent predictor of post-stroke depression in Chinese stroke survivors. Neuropsychiatr Dis Treat. 2018;14:587–596. doi:10.2147/NDT.S15514429497302
   PubMed Web of Science ®Google Scholar
• Hackett ML, Anderson CS. Treatment options for post-stroke depression in the elderly. Aging Health. 2005;1(1):95–105. doi:10.2217/1745509X.1.1.95
   Google Scholar
• Hackett ML, Anderson CS, Hose AO. Management of depression after stroke: a systematic review of pharmacological therapies. Stroke. 2005;36(5):1098–1103. doi:10.1161/01.STR.0000162391.27991.9d15802637
   PubMed Web of Science ®Google Scholar
• Wang J. To investigate the depression after Wuling capsule on ischemic stroke patients serum Hcy, nerve cell factor, single amine neurotransmitter metabolism and the influence of the inflammatory response. Shaanxi J Trad Chin Med. 2018;39(10):1357–1359.
   Web of Science ®Google Scholar
• Zeng ML, Chen L, Li B, et al. Effects of xiaoyao pill combined with fluoxetine in treating post-stroke depression and its influence on the serum 5-serotonin level. Zhejiang J Integr Trad Chin West Med. 2018;28(12):997–999.
   Google Scholar
• Ma YS. Therapeutic effect of Ginkgo biloba extract combined with SSRI drugs on depression in elderly patients with coronary heart disease. Chin Prac Med. 2012;7(19):49–50.
   Google Scholar
• Wu HX, Ge MJ, Hao FL, Zhang X, Yuan LF. Therapeutic effect evaluation of Ginkgo biloba extract united with fluoxetine on acute cerebral infarction depression. Int J Psychiatry. 2016;43(3):474–476.
   Google Scholar
• Ma S, Liu X, Xu Q, et al. Transport of ginkgolides with different lipophilicities based on an hCMEC/D3 cell monolayer as a blood–brain barrier cell model. Life Sci. 2014;114(2):93–101. doi:10.1016/j.lfs.2014.08.00625139831
   PubMed Web of Science ®Google Scholar
• Maclennan KM, Darlington CL, Smith PF. The CNS effects of Ginkgo biloba extracts and ginkgolide B. Prog Neurobiol. 2002;67(3):235–257.12169298
   PubMed Web of Science ®Google Scholar
• Bai S, Zhang X, Chen Z, et al. Insight into the metabolic mechanism of Diterpene Ginkgolides on antidepressant effects for attenuating behavioural deficits compared with venlafaxine. Sci Rep. 2017;7(1):9591. doi:10.1038/s41598-017-10391-128852120
   PubMed Web of Science ®Google Scholar
• Hu Q, Shen P, Bai S, et al. Metabolite-related antidepressant action of diterpene ginkgolides in the prefrontal cortex. Neuropsychiatr Dis Treat. 2018;14:999–1011. doi:10.2147/NDT.S16135129713170
   PubMed Web of Science ®Google Scholar
• Liang Z, Bai S, Shen P, et al. GC-MS-based metabolomic study on the antidepressant-like effects of diterpene ginkgolides in mouse hippocampus. Behav Brain Res. 2016;314:116–124. doi:10.1016/j.bbr.2016.08.00127498146
   PubMed Web of Science ®Google Scholar
• Cheng SY, Zhao YD, Li J, et al. Plasma levels of glutamate during stroke is associated with development of post-stroke depression. Psychoneuroendocrinology. 2014;47:126–135. doi:10.1016/j.psyneuen.2014.05.00625001962
   PubMed Web of Science ®Google Scholar
• Williams JBW. A structured interview guide for the Hamilton depression rating scale. Arch Gen Psychiatry. 1988;45(8):742–747. doi:10.1001/archpsyc.1988.018003200580073395203
   PubMed Web of Science ®Google Scholar
• Zheng P, Chen J, Huang T, et al. A novel urinary metabolite signature for diagnosing major depressive disorder. J Proteome Res. 2013;12(12):5904–5911. doi:10.1021/pr400939q24224655
   PubMed Web of Science ®Google Scholar
• Hou L, Wei X, Zhuo Y, et al. GC-MS-based metabolomics approach to diagnose depression in hepatitis B virus-infected patients with middle or old age. Aging (Albany NY). 2018;10(9):2252. doi:10.18632/aging.10144630178754
   PubMedGoogle Scholar
• Guilloux JP, Douillard-Guilloux G, Kota R, et al. Molecular evidence for BDNF- and GABA-related dysfunctions in the amygdala of female subjects with major depression. Mol Psychiatry. 2012;17:1130–1142. doi:10.1038/mp.2011.11321912391
   PubMed Web of Science ®Google Scholar
• Saxena SK, Ng TP, Koh G, Yong D, Fong NP. Is improvement in impaired cognition and depressive symptoms in post-stroke patients associated with recovery in activities of daily living? Acta Neurol Scand. 2007;115:339–346. doi:10.1111/j.1600-0404.2006.00751.x17489945
   PubMed Web of Science ®Google Scholar
• Passaro A, Soavi C, Marusic U, et al. Computerized cognitive training and brain derived neurotrophic factor during bed rest: mechanisms to protect individual during acute stress. Aging (Albany NY). 2017;9(2):393–407. doi:10.18632/aging.10116628161695
   PubMedGoogle Scholar
• Sato Y, Chin Y, Kato T, et al. White matter activated glial cells produce BDNF in a stroke model of monkeys. Neurosci Res. 2009;65(1):71–78. doi:10.1016/j.neures.2009.05.01019501123
   PubMed Web of Science ®Google Scholar
• Nomoto H, Baba H, Satomura E, et al. Serum brain derived neurotrophic factor levels and personality traits in patients with major depression. BMC Psychiatry. 2015;15:33. doi:10.1186/s12888-015-0413-125885038
   PubMed Web of Science ®Google Scholar
• Karege F, Perret G, Bondolfi G, et al. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res. 2002;109(2):143–148.11927139
   PubMed Web of Science ®Google Scholar
• Zhou C, Zhong J, Zou B, et al. Meta-analyses of comparative efficacy of antidepressant medications on peripheral BDNF concentration in patients with depression. PLoS One. 2017;12(2):e0172270. doi:10.1371/journal.pone.017227028241064
   PubMed Web of Science ®Google Scholar
• Shen P, Hu Q, Dong M, et al. Venlafaxine exerts antidepressant effects possibly by activating MAPK–ERK1/2 and P13K–AKT pathways in the hippocampus. Behav Brain Res. 2017;335:63–70. doi:10.1016/j.bbr.2017.08.01128797602
   PubMed Web of Science ®Google Scholar
• Hickie IB, Rogers NL. Novel melatonin-based therapies: potential advances in the treatment of major depression. Lancet. 2011;378(9791):621–631. doi:10.1016/S0140-6736(11)60095-021596429
   PubMed Web of Science ®Google Scholar
• Zhao X, Cao F, Liu Q, et al. Behavioral, inflammatory and neurochemical disturbances in LPS and UCMS-induced mouse models of depression. Behav Brain Res. 2019;364:494–502. doi:10.1016/j.bbr.2017.05.06428572058
   PubMed Web of Science ®Google Scholar
• Martinowich K, Lu B. Interaction between BDNF and serotonin: role in mood disorders. Neuropsychopharmacology. 2008;33(1):73–83. doi:10.1038/sj.npp.130157117882234
   PubMed Web of Science ®Google Scholar
• Chen J, Bai SJ, Li W, et al. Urinary biomarker panel for diagnosing patients with depression and anxiety disorders. Transl Psychiatry. 2018;8(1):192. doi:10.1038/s41398-018-0245-030232320
   PubMed Web of Science ®Google Scholar
• Chen J, Xie J, Zeng L, et al. Urinary metabolite signature in bipolar disorder patients during depressive episode. Aging (Albany NY). 2019;11(3):1008–1018. doi:10.18632/aging.10180530721880
   PubMedGoogle Scholar